Literature DB >> 25380420

Landmark approvals in idiopathic pulmonary fibrosis.

Mark Ratner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25380420     DOI： 10.1038/nbt1114-1069

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  At the frontiers of lung fibrosis therapy.

Authors: 
Journal:  Nat Biotechnol       Date:  2013-09       Impact factor: 54.908

2.  Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in Mammalian lung fibrosis.

Authors:  Yang Zhou; Hong Peng; Huanxing Sun; Xueyan Peng; Chuyan Tang; Ye Gan; Xiaosong Chen; Aditi Mathur; Buqu Hu; Martin D Slade; Ruth R Montgomery; Albert C Shaw; Robert J Homer; Eric S White; Chang-Min Lee; Meagan W Moore; Mridu Gulati; Chun Geun Lee; Jack A Elias; Erica L Herzog
Journal:  Sci Transl Med       Date:  2014-06-11       Impact factor: 17.956

3.  Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.

Authors:  Luca Richeldi; Roland M du Bois; Ganesh Raghu; Arata Azuma; Kevin K Brown; Ulrich Costabel; Vincent Cottin; Kevin R Flaherty; David M Hansell; Yoshikazu Inoue; Dong Soon Kim; Martin Kolb; Andrew G Nicholson; Paul W Noble; Moisés Selman; Hiroyuki Taniguchi; Michèle Brun; Florence Le Maulf; Mannaïg Girard; Susanne Stowasser; Rozsa Schlenker-Herceg; Bernd Disse; Harold R Collard
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245
  3 in total
  4 in total

Review 1.  Engineering approaches to study fibrosis in 3-D in vitro systems.

Authors:  Ana M Porras; Heather N Hutson; Anthony J Berger; Kristyn S Masters
Journal:  Curr Opin Biotechnol       Date:  2016-02-27       Impact factor: 9.740

2.  Safety and Efficacy of Allogeneic Lung Spheroid Cells in a Mismatched Rat Model of Pulmonary Fibrosis.

Authors:  Jhon Cores; M Taylor Hensley; Kathryn Kinlaw; S Michaela Rikard; Phuong-Uyen Dinh; Dipti Paudel; Junnan Tang; Adam C Vandergriff; Tyler A Allen; Yazhou Li; Jianhua Liu; Bo Niu; Yuepeng Chi; Thomas Caranasos; Leonard J Lobo; Ke Cheng
Journal:  Stem Cells Transl Med       Date:  2017-08-07       Impact factor: 6.940

3.  Interplay between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis.

Authors:  William R Coward; Oliver J Brand; Alice Pasini; Gisli Jenkins; Alan J Knox; Linhua Pang
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 6.914

4.  Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centres.

Authors:  Helen E Jo; Tamera J Corte; Yuben Moodley; Kovi Levin; Glen Westall; Peter Hopkins; Daniel Chambers; Ian Glaspole
Journal:  BMC Pulm Med       Date:  2016-02-01       Impact factor: 3.317
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.